ScholarIQanswers from OpenAlex

<scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2

PaperCitations, authors & open-access status

<scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 have?

ScholarIQcitation count

<scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 has 97 citations in the OpenAlex counts ScholarIQ stores.

When was <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 published?

ScholarIQyear

<scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 has 2014 year in the ScholarIQ index.

What is the open-access status of <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2?

ScholarIQoa status

<scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 has closed oa status in the ScholarIQ index.

What is the DOI of <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2?

ScholarIQdoi

The DOI for <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 is on the source record.

What is the PMID of <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2?

ScholarIQpmid

The PMID for <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 is on the source record.

What is the OpenAlex record for <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2?

ScholarIQopenalex

The OpenAlex for <scp>MicroRNA</scp>‐542‐3p inhibits tumour angiogenesis by targeting Angiopoietin‐2 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial